Cegedim Sa · EURONEXT:ALCGM

Cegedim Sa — Q2 2015 Earnings Presentation

33 slides from Cegedim Sa's earnings presentation, Sep 28, 2015

1. Slide 1: Q2 2015 Earnings Conference Call

   Q2 2015 EARNINGS Conference Call September 28, 2015 at 6:15pm CET

2. Slide 2: Safe Harbor Statement

   SAFE HARBOR STATEMENT This presentation contains forward-looking statements (made pursuant to the safe harbour provisions of the Private Securities Litigation Reform Act of 1995). By their nature, forward-looking statements involve risk and uncertainty. Forward-looking statements represent the compa

3. Slide 3: IFRS 5

   IFRS 5 Cegedim announced on April 1st, 2015, that it had completed the disposal of its CRM and Strategic Data division to IMS Health for an estimated selling price of €396 million. This estimated amount is subject to joint review over a period of 180 business days. Consequently its HY-2015 Financial

4. Slide 4: Cegedim at a Glance in 2015

   Cegedim at a Glance in 2015 Q2 2015 Earnings – Sep. 2015 4

5. Slide 5: Agenda

   AGENDA.  Business Group Review  HY 2015 Financial Situation 5

6. Slide 6: Business Group Review

   Business Group Review

7. Slide 7: HY 2015 Key Takeaway

   HY 2015 Key Takeaway Q2 2015 Earnings – Sep. 2015 7

8. Slide 8: HY 2015 Financial Key Takeaway

   HY 2015 Financial Key Takeaway Q2 2015 Earnings – Sep. 2015 8

9. Slide 9: Breakdown of Activities by Division

   Breakdown of Activities by Division Q2 2015 Earnings – Sep. 2015 9

10. Slide 10: HY 2015 Performance by Division

    HY 2015 Performance by Division Q2 2015 Earnings – Sep. 2015 10

11. Slide 11: Health Insurance, HR & e-services Division Overview

    Health Insurance, HR & e-services Division Overview Q2 2015 Earnings – Sep. 2015 11

12. Slide 12: Healthcare Professionals Division Overview

    Healthcare Professionals Division Overview Q2 2015 Earnings – Sep. 2015 12

13. Slide 13: Cegelease Division Overview

    Cegelease Division Overview Q2 2015 Earnings – Sep. 2015 13

14. Slide 14: Strategic Priorities

    Strategic Priorities Q2 2015 Earnings – Sep. 2015 14

15. Slide 15: HY 2015 Financial Situation

    HY 2015 Financial Situation

16. Slide 16: HY 2015 Revenue Growth

    HY 2015 Revenue Growth Q2 2015 Earnings – Sep. 2015 16

17. Slide 17: HY 2015 Performance by Division

    HY 2015 Performance by Division Q2 2015 Earnings – Sep. 2015 17

18. Slide 18: Revenue Breakdown from Continuing Activities

    Revenue Breakdown from Continuing Activities Q2 2015 Earnings – Sep. 2015 18

19. Slide 19: HY 2015 P&L

    HY 2015 P&L Q2 2015 Earnings – Sep. 2015 19

20. Slide 20: HY 2015 Performance by Division

    HY 2015 Performance by Division Q2 2015 Earnings – Sep. 2015 20

21. Slide 21: HY 2015 Net Debt Change

    HY 2015 Net Debt Change Q2 2015 Earnings – Sep. 2015 21

22. Slide 22: HY 2015 Consolidated Balance Sheet

    HY 2015 Consolidated Balance Sheet Q2 2015 Earnings – Sep. 2015 22

23. Slide 23: Upgraded to BB-, Positive Outlook

    Upgraded to BB-, Positive Outlook Q2 2015 Earnings – Sep. 2015 23

24. Slide 24: Use of Proceed from the IMS Health Transaction

    Use of Proceed from the IMS Health Transaction Q2 2015 Earnings – Sep. 2015 24

25. Slide 25: FY 2015 Outlook

    FY 2015 Outlook Q2 2015 Earnings – Sep. 2015 25

26. Slide 26: Next Events

    Next Events Q2 2015 Earnings – Sep. 2015 26

27. Slide 27: Annexes

    Annexes

28. Slide 28: FY Performance by Division

    FY Performance by Division Q2 2015 Earnings – Sep. 2015 28

29. Slide 29: Cegelease: P&L Impact between self-financed and resold contracts

    Cegelease: P&L Impact between self-financed and resold contracts Q2 2015 Earnings – Sep. 2015 29

30. Slide 30: Cegedim Strengths

    Cegedim Strengths Q2 2015 Earnings – Sep. 2015 30

31. Slide 31: Cegedim is Well-Positioned

    Cegedim is Well-Positioned Q2 2015 Earnings – Sep. 2015 31

32. Slide 32: 2015 Financial Agenda

    2015 Financial Agenda Q2 2015 Earnings – Sep. 2015 32

33. Slide 33: We welcome your questions and comments

    We welcome your questions and comments Jan Eryk UMIASTOWSKI Chief Investment Officer - Head of Investor Relations janeryk.umiastowski@cegedim.com

Cegedim — Q2 2015 Earnings Presentation on 6ix